Venus Remedies Limited, a leading research based pharmaceutical company has announced to enter super specialty oncology segment with the launch of a new dedicated sub-business unit ‘Passion Oncobiz’ with a product basket of 21 products covering cancer types, like lung cancer, breast cancer, cervical cancer, brain tumour and oral cancer, in injectable form for practically fighting all types of cancer.
Venus Remedies CMD Pawan Chaudhary said, “At present, the anti-cancer drug segment is contributing 30 per cent of the total sales of the company with more than 100 market authorisations from 25 countries including UK, Germany, Poland, Portugal; and with this launch, Venus will further reinforce its industry position and expects a 10 per cent growth in the market share by 2015”.
The domestic market is growing at a rate of 30 per cent annually and the current sales’ estimate of anti-cancer products is $150-200 million a year. With 35 qualified professionals, this special marketing cell will offer affordable life-saving medicines to the Indian masses. The business unit will cover Indian institutes, government and private, to facilitate the therapies.